Skip to content

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

a RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing ™

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01301417
Acronym
RETROPRESS
Enrollment
171
Registered
2011-02-23
Start date
2011-02-28
Completion date
2011-08-31
Last updated
2013-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colitis, Ulcerative, Colorectal Neoplasms, Colostomy, Crohn Disease, Diverticulum, Colon, Endometriosis, Ileostomy - Stoma, Intestinal Polyposis, Intestinal Volvulus, Lymphoma, Rectal Prolapse

Keywords

Compression Anastomosis

Brief summary

The proposed study is a post marketing, observational, retrospective data collection intended to gather and record data on patients treated with the ColonRing™ device in routine clinical practice at a single center. The data will assist in further evaluating the performance of the ColonRing™ device in regards to the creation of a colorectal anastomosis. Hypothesis:The performance of the ColonRing™, determined by the rate of complications, will be within the acceptable range reported in the literature for alternative treatment modalities.

Interventions

DEVICEColonRing™

Creation of a circular Compression Anastomosis

Sponsors

novoGI
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient was \> 18 years old at time of procedure * Patient underwent an open or laparoscopic colorectal procedure with the creation of an anastomosis using the ColonRing™ * Patient treated in routine clinical practice following marketing clearance of the device within the cleared intended use * Patient underwent his/her first follow-up visit within two months post-surgery

Exclusion criteria

* No

Design outcomes

Primary

MeasureTime frameDescription
Rate of anastomotic leakage2-mo post-opThe primary study outcome is the rate of anastomotic leakage. Anastomotic leakage is defined as evidence of a defect in the intestinal wall integrity at the anastomotic site leading to a communication between the intra and extra luminal compartments.

Secondary

MeasureTime frameDescription
Rate of other device related complications and measures during hospitalization and post procedure:2-mo post-opThe following complications will be examined for relation to the device: Bleeding. Stricture (either clinical evidence of a stricture or the inability to pass a 12 mm sigmoidoscope through the anastomosis in a procedure that does not include a diversion). Septic complication (including wound infection, pelvic infection, peritonitis, abscess). Readmission, re-operation, death within two months of the procedure. Extra colonic complications (including urinary infection, urinary retention, DVT, pneumonitis, pulmonary embolism, cardiac, injury to other organs - e.g. spleen, ureter)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026